Related references
Note: Only part of the references are listed.Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Wenhua Liang et al.
LANCET ONCOLOGY (2020)
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
James M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 and Italy: what next?
Andrea Remuzzi et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
Timothy P. Hanna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
Yue-Nan Ni et al.
CRITICAL CARE (2019)
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Encouraging Trends in Modern Phase 1 Oncology Trials
Camille Chakiba et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms AMeta-analysis
Maria Schwaederle et al.
JAMA ONCOLOGY (2016)
Share Paper
